全球精准诊断市场规模、份额、趋势及成长分析报告（2026-2034）

预计精准诊断市场将从 2025 年的 235.5 亿美元成长到 2034 年的 1,123.5 亿美元，2026 年至 2034 年的复合年增长率为 18.96%。

随着医疗保健系统向个人化医疗和标靶治疗模式转变，全球精准诊断市场正在快速成长。精准诊断利用基因检测、分子诊断和生物标记分析等先进技术，更准确地识别疾病。这些工具能够帮助医生为每位患者选择最有效的治疗方法。

市场成长的主要驱动因素之一是癌症和遗传性疾病等慢性病盛行率的不断上升。医疗服务提供者正在采用先进的诊断工具来早期发现疾病并制定个人化的治疗方案。生物技术研发和基因组学领域投资的不断增加也推动了市场成长。

随着医疗保健产业向个人化和数据驱动的治疗策略转变，精准诊断市场预计将显着成长。基因测序、人工智慧和数位健康技术的进步将提高诊断准确性。随着医疗服务提供者越来越重视早期检测和精准医疗，对先进诊断解决方案的需求将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球精准诊断市场：依类型划分

• 市场分析、洞察与预测
• 基因检测
• 消费者测试
• 特殊检查
• 其他的

第五章 全球精准诊断市场：依应用划分

• 市场分析、洞察与预测
• 肿瘤学
• 呼吸系统疾病
• 皮肤病
• 中枢神经系统疾病
• 免疫学
• 遗传性疾病
• 其他的

第六章：全球精准诊断市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 临床检查室
• 其他的

第七章 全球精准诊断市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • BioMerieux SA
  • Becton, Dickinson And Company
  • Danaher Corporation
  • QIAGEN NV
  • Hologic Inc
  • Agilent Technologies Inc

The Precision Diagnostics Market size is expected to reach USD 112.35 Billion in 2034 from USD 23.55 Billion (2025) growing at a CAGR of 18.96% during 2026-2034.

The global precision diagnostics market is growing rapidly as healthcare systems focus on personalized medicine and targeted treatment approaches. Precision diagnostics involves using advanced technologies such as genetic testing, molecular diagnostics, and biomarker analysis to identify diseases more accurately. These tools help doctors select the most effective treatments for individual patients.

One of the major drivers of the market is the increasing prevalence of chronic diseases such as cancer and genetic disorders. Healthcare providers are adopting advanced diagnostic tools to detect diseases at an early stage and develop personalized treatment plans. Growing investments in biotechnology research and genomic technologies are also supporting market expansion.

In the future, the precision diagnostics market is expected to expand significantly as healthcare moves toward personalized and data-driven treatment strategies. Advances in genomic sequencing, artificial intelligence, and digital health technologies will improve diagnostic accuracy. As healthcare providers focus more on early detection and precision medicine, demand for advanced diagnostic solutions will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

By Application

• Oncology
• Respiratory Diseases
• Skin Diseases
• CNS Disorders
• Immunology
• Genetic Diseases
• Others
• By-End-use
• Hospitals
• Clinical Laboratories
• Others

COMPANIES PROFILED

• Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, bioMrieux SA, Becton, Dickinson and Company, Danaher Corporation, QIAGEN NV, Hologic Inc, Agilent Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECISION DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Genetic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Direct to Consumer Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Esoteric Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECISION DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Skin Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CNS Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Genetic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECISION DIAGNOSTICS MARKET: BY BY-END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast By-end-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECISION DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By By-end-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By By-end-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By By-end-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By By-end-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By By-end-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PRECISION DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 F. Hoffmann-La Roche Ltd
  • 9.2.3 Siemens Healthineers AG
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 BioMerieux SA
  • 9.2.6 Becton, Dickinson And Company
  • 9.2.7 Danaher Corporation
  • 9.2.8 QIAGEN N.V
  • 9.2.9 Hologic Inc
  • 9.2.10 Agilent Technologies Inc